Navigation Links
FDA Approves EDARBI (azilsartan medoxomil) for the Treatment of Hypertension
Date:2/25/2011

DEERFIELD, Ill. and OSAKA, Japan, Feb. 25, 2011 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration (FDA) approved EDARBI (azilsartan medoxomil) for the treatment of hypertension, or high blood pressure, in adults. EDARBI is an angiotensin II receptor blocker (ARB) that lowers blood pressure by blocking the action of angiotensin II, a vasopressor hormone that constricts blood vessels. When the angiotensin II receptor is blocked, blood vessels stay relaxed and open and blood pressure can be reduced. EDARBI is approved as a once-daily oral therapy for use alone and for use in combination with other antihypertensive medications.

Takeda Global Research & Development Center, Inc. U.S. submitted a new drug application (NDA) for EDARBI in April 2010. The NDA was supported by seven controlled phase 3 clinical trials involving more than 5,900 patients with hypertension. Pivotal phase 3 studies showed EDARBI (80 mg/day) was statistically superior to placebo and the highest approved doses of two commonly prescribed ARBs, olmesartan medoxomil (40 mg/day) and valsartan (320 mg/day), in lowering both clinic and 24-hour mean blood pressure measurements.

"We are pleased to be able to build upon our global expertise in the cardiovascular therapeutic area with the approval of EDARBI in the U.S.," said Shinji Honda, president and CEO, Takeda Pharmaceuticals North America. "Through the discovery, development and commercialization of new medicines, Takeda is committed to bringing therapies like EDARBI to market. EDARBI is an important new treatment option for patients with hypertension and the health care professionals who treat them."

The safety and efficacy of EDARBI were studied as a once-daily oral therapy, as well as in combination with chlorthalidone and amlodipine. Results from the phase 3 clinical trials sh
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Product to Prevent Bleeding in People With Rare Genetic Defect
2. FDA Approves First 3-D Mammography Imaging System
3. FDA Approves 1st Pacemaker Designed to Work Safely During Some MRI Exams
4. FDA Approves Hologics Makena™ (Formerly Referred to as Gestiva™) Pharmaceutical
5. FDA Approves Drug to Reduce Risk of Preterm Birth in At-Risk Pregnant Women
6. FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth
7. FDA Approves Viibryd to Treat Major Depressive Disorder
8. FDA Approves Head Lice Treatment for Children and Adults
9. FDA Approves Opioid Analgesic to Help Cancer Patients Manage Pain
10. VIDEO from Endo Pharmaceuticals Available on thenewsmarket.com: FDA Approves New Treatment for Low Testosterone
11. FDA Approves New Dosage Strength for INTELENCE®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... Pa. , July 1, 2015 ... fully integrated specialty pharmaceutical company focused on developing, ... that Bob Radie , president and chief ... conferences this summer. He will provide an update ... (ketorolac tromethamine) Nasal Spray, approved product ...
(Date:7/1/2015)... July 1, 2015 New exchange plan enrollees ... 2015 compared to the same time a year ago, ... (NASDAQ: ESRX ) Exchange Pulse™ report, released today. ... 2014, the number of new exchange plan enrollees who ... in the first quarter of 2015. However, when evaluating ...
(Date:7/1/2015)... The Haselmeier Group has decided ... Gert Weber has been nominated by the Board ... Executive Officer (CEO) of the Haselmeier Group. This ... Mr. Weber brings more than 20 years of experience ... various executive management positions, the last being Managing Director ...
Breaking Medicine Technology:Egalet to Present at Upcoming Conferences This Summer 2Egalet to Present at Upcoming Conferences This Summer 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 2Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 5Haselmeier Group Announces the Extension and Reorganization of its Executive Board 2
... 14 ERT (Nasdaq: ERES ) announced today that it will ... 2010 , after the market closes. After the release, the Company will host ... , , ... dial 1-800-860-2442 when calling within the United States or 1-412-858-4600 when ...
... PALO ALTO, Calif. , July 14 ... developed a medical device and procedure to treat vaginal ... accepted for the 2010 International Meetings for the International ... as a joint meeting in 2010, and the International ...
Cached Medicine Technology:ERT to Announce Second Quarter 2010 Results on August 9, 2010 2Viveve-Sponsored Research Accepted for Presentation at Two Prestigious International Conferences 2Viveve-Sponsored Research Accepted for Presentation at Two Prestigious International Conferences 3
(Date:7/1/2015)... LENEXA, Kan. (PRWEB) , ... July 01, 2015 ... ... firm dedicated exclusively to healthcare providers, has been retained to lead a national ... One of the top executive search firms in the healthcare industry, B. E. ...
(Date:7/1/2015)... CA (PRWEB) , ... July 01, 2015 , ... Research ... Examination Kit (Peek) smartphone app to test eyesight was just as accurate as those ... School of Hygiene and Tropical Medicine is responsible for the development of the test, ...
(Date:7/1/2015)... ... 01, 2015 , ... The Recovery Workforce Summit: 2015 PRA Annual Conference ... of The Atlantic, as a keynote on June 2nd in Philadelphia, PA. Stossel led ... personal story added power and reach to the essential message, while opening doors to ...
(Date:7/1/2015)... Salt Lake City, UT (PRWEB) , ... July ... ... opportunity to compare the different philosophies and approaches to case management, placement, sober ... also have different training and approaches to working with and transporting clients with ...
(Date:7/1/2015)... ... July 01, 2015 , ... AvePoint, the established ... of a new operational office in Zurich, Switzerland. The new facility will deliver ... of business for organizations throughout the Swiss market. , “AvePoint is committed ...
Breaking Medicine News(10 mins):Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 2Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 3Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 2Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 3Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 2Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 3Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 4Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 5Health News:All Kinds of Therapy – Announces New Partnership Feature, Therapeutic Experts 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 3
... Technical and Naturals Pavilions are Sold-Out and Sustainable Packaging ... ... in raw,materials, technical equipment, naturals products, and sustainable,packaging will be on ... 11 at the Jacob K. Javits Convention Center in New York.,Both ...
... Pa., Sept. 4 PA Fluoride NOW, a,coalition ... to improving oral health in Pennsylvania, has added,an ... let residents find out,if the water they drink ... teeth., "Just over half of Pennsylvania,s citizens ...
... Few things are more important than,knowing whether ... safe. While some,foods have come under fire for ... an unfair rap., Listen to this report ... http://media.medialink.com/WebNR.aspx?story=35524 , Registered journalists can access video, ...
... Illinois professor of psychology Dolores Albarracn and her colleagues ... Health Department in Florida found a method to increase ... The study, which appeared this month in the journal ... experimental introduction to a counseling session, public health institutions ...
... Pharma(TM), a focus,area within SAFC(R) ( http://www.safcpharma.com ), ... ), today officially announced details,of a $30 million ... significantly increase its capacity to produce commercial scale,High ... purchase of 15 acres of green space in ...
... HHS Secretary Mike,Leavitt today welcomed 11 more community ... health care system where consumers, providers,and payers make ... care., These communities will join 14 others ... health care providers, employers,insurers, and consumers working jointly ...
Cached Medicine News:Health News:HBA Exhibit Floor Offers Global Resources to the Beauty and Personal Care Industry 2Health News:HBA Exhibit Floor Offers Global Resources to the Beauty and Personal Care Industry 3Health News:PA Fluoride NOW Debuts Interactive Map for Residents to Learn if Their Water Has the Best Fluoride Level to Protect Teeth 2Health News:PA Fluoride NOW Debuts Interactive Map for Residents to Learn if Their Water Has the Best Fluoride Level to Protect Teeth 3Health News:Neutral HIV presentations more likely to be considered inviting, study finds 2Health News:SAFC Pharma(TM) Commits to Major Expansion of High Potency API Production at Madison Site 2Health News:SAFC Pharma(TM) Commits to Major Expansion of High Potency API Production at Madison Site 3Health News:HHS Designates 11 Communities Working to Improve Quality and Value of Health Care As Chartered Value Exchanges 2Health News:HHS Designates 11 Communities Working to Improve Quality and Value of Health Care As Chartered Value Exchanges 3
... Simplex™ P with Tobramycin ... Bone Cement formula, with the ... By maintaining the original formula, ... performance characteristics of Simplex™ P ...
... Flow Analyzer is a fast, clinically proven ... of low and normal-tension glaucoma., ,The Ocular ... clinically proven measurement that improves detection of ... management of glaucoma, and detection of other ...
... Flexible Dosposable Easy Insertion/Removal ... (CSS) provides absolutely reliable support to ... thereby permitting routine phacoemulsification regardless of ... easy (similar to disposable iris retractors), ...
The collagen intracanicular plugs have a smooth proprietary finish that simplifies insertion of the plug. Collagen plugs are ideal for short term, diagnostic and post-surgical occlusion. Plugs are 2m...
Medicine Products: